Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout
Clinical trial NCT05253833 · COMPLETED
Trial details
- NCT number
- NCT05253833
- Sponsor
- Arthrosi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2024-08-13
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.